Inventor
WALKER ANN LOUISE
GB35 patents
⚠️ This page may combine multiple inventors who share the name “WALKER ANN LOUISE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLAXO GROUP LTD
13 patentsUS7166623B2Jan 23, 2007
2′-Methyl-5′-(1,3,4-oxadiazol-2-yl)-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
GLAXO GROUP LTD22 citations92
US7151118B2Dec 19, 2006
Biphenylcarboxylic amide derivatives as p38-kinase inhibitors
GLAXO GROUP LTD27 citations91
US7384963B2Jun 10, 2008
2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase
GLAXO GROUP LTD15 citations84
US7396843B2Jul 8, 2008
5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
GLAXO GROUP LTD12 citations83
US7309800B2Dec 18, 2007
Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
GLAXO GROUP LTD17 citations83
US7208629B2Apr 24, 2007
5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
GLAXO GROUP LTD20 citations83
US7183297B2Feb 27, 2007
Biphenyl-derivatives as p38-kinase inhibitors
GLAXO GROUP LTD14 citations83
US7432289B2Oct 7, 2008
5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
GLAXO GROUP LTD14 citations82
US7166631B2Jan 23, 2007
Benzo[f]isoindole derivatives with affinity to the EP4 receptor
GLAXO GROUP LTD6 citations74
US10039755B2Aug 7, 2018
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
GLAXO GROUP LTD2 citations71
US9833449B2Dec 5, 2017
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
GLAXO GROUP LTD2 citations71
US7732622B2Jun 8, 2010
Naphthalene derivatives
GLAXO GROUP LTD5 citations61
US9518054B2Dec 13, 2016
2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors
GLAXO GROUP LTD2 citations60
GLAXOSMITHKLINE IP DEV LTD
6 patentsUS10246447B2Apr 2, 2019
3-(6-chloro-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazin-4-yl) propanoic acid derivatives and their use as KMO inhibitors
GLAXOSMITHKLINE IP DEV LTD2 citations72
US9932328B2Apr 3, 2018
3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhibitors
GLAXOSMITHKLINE IP DEV LTD2 citations72
US10611756B2Apr 7, 2020
Method of treating pancreatitis using 1,4-benzoxazine derivatives
GLAXOSMITHKLINE IP DEV LTD0 citations51
US10273232B2Apr 30, 2019
3-(6-alkoxy-5-chlorobenzo[D]isoxazol-3-YL)propanoic acid useful as kynurenine monooxygenase inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations51
US10815218B2Oct 27, 2020
Benzoimidazole derivatives as PAD4 inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations49
US10407407B2Sep 10, 2019
Benzoimidazole derivatives as PAD4 inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations49
SMITHKLINE BEECHAM CORP
5 patentsUS7125898B2Oct 24, 2006
Nicotinamide derivatives useful as p38 inhibitors.
SMITHKLINE BEECHAM CORP39 citations96
US7514456B2Apr 7, 2009
Nicotinamide derivatives useful as p38 inhibitors
SMITHKLINE BEECHAM CORP9 citations84
US7425555B2Sep 16, 2008
Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
SMITHKLINE BEECHAM CORP13 citations80
US7572790B2Aug 11, 2009
Biphenyl carboxylic amide p38 kinase inhibitors
SMITHKLINE BEECHAM CORP5 citations62
US6924297B2Aug 2, 2005
Naphathalene derivatives which bind to the EP4 receptor
SMITHKLINE BEECHAM CORP2 citations60
GLAXOSMITHKLINE LLC
3 patentsUS7709506B2May 4, 2010
Nicotinamide derivatives useful as p38 inhibitors
GLAXOSMITHKLINE LLC5 citations73
US7838540B2Nov 23, 2010
3-aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as p38 kinase inhibitors
GLAXOSMITHKLINE LLC3 citations63
US7687532B2Mar 30, 2010
Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis
GLAXOSMITHKLINE LLC5 citations61